{"url_path":"/sec/cik-0001465470/10-k/2026/item-10","section_key":"item-10","section_title":"Item 10 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1465470/0001493152-26-034187-index.html","accession_number":"0001493152-26-034187","cik":"0001465470","ticker":null,"issuer_name":"NaturalShrimp Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1465470/0001493152-26-034187-index.html","primary_entity_key":"0001465470","primary_entity_name":"NaturalShrimp Inc"},"word_count":674,"has_tables":true,"body_markdown":"**ITEM\n10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**\n\n \n\nAs\nof March 31, 2026, David Antelo was the Company’s i) chief executive officer ii) chief financial officer and iii) sole Director.\n\n \n\n*Biographies*\n\n \n\n**David\nAntelo – Chief Executive Officer, Chief Financial Officer and Sole Director**\n\n** **\n\nDavid\nAntelo has served as a founder, executive, and operator in the water technology and aquaculture sectors for over a decade. From 2018\nthrough the present, he has been actively leading and developing Hydrenesis, a company focused on advancing proprietary technologies\nfor water treatment, aquaculture systems, and environmental remediation.\n\n \n\nDuring\nthe past five years, Mr. Antelo has been responsible for structuring and executing the commercialization strategy for Hydrenesis technologies,\nincluding electrocoagulation-based treatment systems and hydrogen-based water treatment applications. His role has included negotiating\nand structuring licensing agreements, overseeing intellectual property positioning, and identifying market applications across aquaculture,\nagriculture, and industrial wastewater sectors.\n\n \n\nMr.\nAntelo is also the founder of HydrEvolve Inc., a U.S.-based company focused on the development of decentralized water purification systems\nfor disaster relief, off-grid communities, and industrial applications. His responsibilities include product strategy, commercialization\nplanning, and coordination of engineering and prototype development. HydrEvolve Inc. is not a parent or subsidiary of the registrant\nbut is an affiliated entity under common control.\n\n \n\nMr.\nAntelo has also led capital formation efforts, strategic partnerships, and product development initiatives tied to these technologies.\nHis work has included coordinating engineering development, guiding prototype deployment, and aligning technical capabilities with commercial\nopportunities.\n\n \n\nIn\naddition, Mr. Antelo spent approximately 17 years as an investment advisor, where he was responsible for advising clients on capital\nallocation, financial planning, and investment strategies. This experience provides a foundation in capital markets, investor relations,\nand financial structuring, which is directly applicable to the management and oversight of a publicly traded company.\n\n \n\n*Family\nRelationships*\n\n \n\nNot\napplicable\n\n \n\n*Involvement\nin Certain Legal Proceedings*\n\n \n\nNot\napplicable\n\n \n\n*Meetings\nof the Board; Committees*\n\n \n\nWe\ndo not currently have a standing audit, nominating or compensation committee of the Board of Directors, or any committee performing similar\nfunctions. Our sole director performs the functions of audit, nominating and compensation committees.\n\n \n\n*Audit\nCommittee*\n\n \n\nOur\nBoard of Directors has not established a separate audit committee within the meaning of Section 3(a)(58)(A) of the Exchange Act. Instead,\nour sole director acts as the audit committee within the meaning of Section 3(a)(58)(B) of the Exchange Act and will continue to do so\nuntil such time as a separate audit committee has been established.\n\n \n\n*Audit\nCommittee Financial Expert*\n\n \n\nWe\ncurrently have not designated anyone as an “audit committee financial expert,” as defined in Item 407(d)(5) of Regulation\nS-K, as we have not yet created an audit committee of the Board of Directors.\n\n \n\n*Nominations\nto the Board of Directors*\n\n \n\nThe\nCompany currently only has a single director and may evaluate the addition of qualified directors as its transition plan, financing needs,\nand operating activities develop.\n\n \n\n*Director\nNominations*\n\n \n\nAs\nof March 31, 2026, we did not effect any material changes to the procedures by which our shareholders may recommend nominees to our Board\nof Directors.\n\n \n\n*Board\nLeadership Structure and Role on Risk Oversight*\n\n \n\nDavid\nAntelo currently serves as our Chief Executive Officer, Chief Financial Officer and sole director. We have determined that our leadership\nstructure was appropriate for the Company due to our small size and limited operations and resources. Mr. Antelo will continue to evaluate\nthe Company’s leadership structure and modify as appropriate based on the size, resources and operations of the Company. It is\nanticipated that the Board of Directors will establish procedures to determine an appropriate role for the Board of Directors in our\nrisk oversight function.\n\n \n\n10\n\n \n\n \n\n*Compensation\nCommittee Interlocks and Insider Participation*\n\n \n\nNo\ninterlocking relationship exists between our board of directors and the board of directors or compensation committee of any other company,\nnor has any interlocking relationship existed in the past.\n\n \n\n*Code\nof Ethics*\n\n \n\nWe\nhave adopted a written code of ethics that applies to our chief executive officer and chief financial officer. A copy of such code of\nethics is available upon written request to the Company."}